Prior SARS-CoV-2 infection increases reactogenicity after SARS-COV-2 mRNA vaccine and could delay the administration of the vaccine based on timing of infection.
作者信息
Stellini Roberto, Gianello Renzo, Meloni Angelo, Croce Elia, Materzanini Paola, Gomarasca Walter
机构信息
Infectious Diseases Service, Health Care Department, Poliambulanza Foundation Hospital, Brescia, Italy.
Department of Clinical Laboratory, Poliambulanza Foundation Hospital, Brescia, Italy.
出版信息
Infection. 2022 Jun;50(3):791-793. doi: 10.1007/s15010-021-01729-z. Epub 2021 Dec 2.
Abstract
摘要
相似文献
1
Prior SARS-CoV-2 infection increases reactogenicity after SARS-COV-2 mRNA vaccine and could delay the administration of the vaccine based on timing of infection.既往感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）会增加接种SARS-CoV-2信使核糖核酸（mRNA）疫苗后的反应原性，并可能根据感染时间延迟疫苗接种。
Infection. 2022 Jun;50(3):791-793. doi: 10.1007/s15010-021-01729-z. Epub 2021 Dec 2.
2
Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura.在首次发生免疫性血小板减少性紫癜后成功进行mRNA SARS-CoV-2疫苗再次接种。
Platelets. 2022 May 19;33(4):652-653. doi: 10.1080/09537104.2022.2044463. Epub 2022 Feb 28.
3
Urticarial vasculitis triggered by SARS-CoV-2 vaccine (mRNA vaccine).由严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗（信使核糖核酸疫苗）引发的荨麻疹性血管炎。
J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e743-e744. doi: 10.1111/jdv.18253. Epub 2022 Jun 3.
4
A fourth SARS-CoV-2 mRNA vaccine in strictly seronegative kidney transplant recipients.严格血清阴性肾移植受者中的第四种SARS-CoV-2 mRNA疫苗。
Kidney Int. 2022 Apr;101(4):825-826. doi: 10.1016/j.kint.2022.01.017. Epub 2022 Feb 12.
5
Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine.SARS-CoV-2 ARCoV mRNA疫苗的安全性和免疫原性。
Lancet Microbe. 2022 Aug;3(8):e561. doi: 10.1016/S2666-5247(22)00150-1. Epub 2022 May 31.
6
Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine.信使核糖核酸新冠疫苗接种后心肌炎风险的Meta分析
Am J Cardiol. 2022 Mar 15;167:155-157. doi: 10.1016/j.amjcard.2021.12.007. Epub 2022 Jan 19.
7
Impact of prior infection status on antibody response to the BNT162b2 mRNA COVID-19 vaccine in healthcare workers at a COVID-19 referral hospital in Milan, Italy.意大利米兰一家 COVID-19 转诊医院的医护人员中既往感染状况对 BNT162b2 mRNA COVID-19 疫苗抗体反应的影响。
Hum Vaccin Immunother. 2021 Dec 2;17(12):4747-4754. doi: 10.1080/21645515.2021.2002639. Epub 2022 Jan 27.
8
COVID-19 mRNA Vaccine Short-Term Safety in Patients With Inflammatory Bowel Disease.炎症性肠病患者中COVID-19 mRNA疫苗的短期安全性
Gastroenterology. 2022 Mar;162(3):987-988. doi: 10.1053/j.gastro.2021.10.004. Epub 2021 Oct 6.
9
Acquired hemophilia A with SARS-CoV-2 mRNA vaccine: first case from Pakistan.新型冠状病毒mRNA疫苗引发的获得性甲型血友病：巴基斯坦首例病例。
Scand J Clin Lab Invest. 2022 Sep;82(5):432-434. doi: 10.1080/00365513.2022.2092902. Epub 2022 Jun 29.
10
High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.新型冠状病毒刺突蛋白受体结合域线性表位在 COVID-19 mRNA 疫苗接种者中的高分辨率线性表位作图。
Microbiol Spectr. 2021 Dec 22;9(3):e0096521. doi: 10.1128/Spectrum.00965-21. Epub 2021 Nov 10.
引用本文的文献
1
Follow-Up of SARS-CoV-2 Antibody Levels in Belgian Nursing Home Residents and Staff Two, Four and Six Months after Primary Course BNT162b2 Vaccination.比利时养老院居民和工作人员在初次接种BNT162b2疫苗后2个月、4个月和6个月时的SARS-CoV-2抗体水平随访
Vaccines (Basel). 2024 Aug 22;12(8):951. doi: 10.3390/vaccines12080951.
2
Antibody response after first and second BNT162b2 vaccination to predict the need for subsequent injections in nursing home residents.首次和第二次接种 BNT162b2 后的抗体反应可预测养老院居民后续接种的需求。
Sci Rep. 2022 Aug 12;12(1):13749. doi: 10.1038/s41598-022-18041-x.
3
Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjects.双重接种 SARS-CoV-2 疫苗的个体和接受 COVID-19 康复者加强针接种的个体的体液免疫。
Infection. 2022 Dec;50(6):1475-1481. doi: 10.1007/s15010-022-01817-8. Epub 2022 Apr 11.
4
Durability of anti-spike antibodies after vaccination with mRNA SARS-CoV-2 vaccine is longer in subjects with previous infection: could the booster dose be delayed?mRNA SARS-CoV-2 疫苗接种后抗刺突抗体的持久性在既往感染者中更长：是否可以延迟加强针接种？
Infection. 2022 Dec;50(6):1573-1577. doi: 10.1007/s15010-022-01816-9. Epub 2022 Apr 7.
本文引用的文献
1
Evolution of enhanced innate immune evasion by SARS-CoV-2.SARS-CoV-2 增强的先天免疫逃避进化。
Nature. 2022 Feb;602(7897):487-495. doi: 10.1038/s41586-021-04352-y. Epub 2021 Dec 23.
2
SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells.SARS-CoV-2 特异性 T 细胞记忆在 COVID-19 恢复期患者中持续存在 10 个月，成功发育出干细胞样记忆 T 细胞。
Nat Commun. 2021 Jun 30;12(1):4043. doi: 10.1038/s41467-021-24377-1.
3
SARS-CoV-2 Antibody Response in Persons with Past Natural Infection.既往自然感染人群中新型冠状病毒2型（SARS-CoV-2）的抗体反应
N Engl J Med. 2021 Jul 1;385(1):90-92. doi: 10.1056/NEJMc2103825. Epub 2021 Apr 14.
4
Evolution of antibody immunity to SARS-CoV-2.SARS-CoV-2 抗体免疫的演变。
Nature. 2021 Mar;591(7851):639-644. doi: 10.1038/s41586-021-03207-w. Epub 2021 Jan 18.
Zotero 插件